Abstract
|
SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma
by Xiaojing Nie, Xiaoting Wang, Youdong Lin, Yinghao Yu, Wei Liu, Feilai Xie, Xuzhou Wang, Jianming Tan, Qiaojia Huang
|
|
|
Background: Cyclin-dependent kinase inhibitor 1A (CDKN1A) and Cyclin D1 (CCND1) play essential roles in the regulation of cell cycle progression and are closely associated with human cancer. CDKN1A and CCND1 single nucleotide polymorphisms (SNPs) have been demonstrated to influence the prognosis in humans with different cancers. However, their roles in the prognosis of patients with resected gastric adenocarcinoma (RGA) remain to be determined.
Methods: Genotypes of CDKN1A rs1059234 and CCND1 rs603965 SNPs were performed in 235 tissue samples from RGA. The association of the genotypes of these two SNPs with the prognosis in the patients with RGA was analyzed by X2 test, multivariate Cox regression analyses, and Kaplan Meier curves.
Results: During the 50 months of median follow-up time, the overall recurrence and survival rate in the whole group was 57.4% and 46.8%, respectively. Whereas, recurrence and survival rate in patients with CC genotype of rs1059234 located in 3′UTR of CDKN1A were 78.0% and 27.1% (p = 0.004; p = 0.006). Multivariate analyses further confirmed that the CC genotype was significantly related with both increased recurrence and death risk (HR 3.33, 95% CI 1.95 - 5.70; p = 1.07 x 10-5, and HR 3.45, 95% CI 1.95 - 6.10; p = 2.03 x 10-5). No significant difference among CCND1 rs603965 SNP with the prognosis was determined.
Conclusions: rs1059234 of CDKN1A is closely associated with the prognosis in patients with RGA.
DOI: 10.7754/Clin.Lab.2015.150722
|
